Premium
What Should Work, May Not
Author(s) -
Kirk A. D.
Publication year - 2010
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/j.1600-6143.2010.03025.x
Subject(s) - medicine , bortezomib , intensive care medicine , engineering ethics , risk analysis (engineering) , multiple myeloma , engineering
When new agents such as bortezomib appear, it is important to maintain scientific rigor regarding off‐label use of medications.
See brief communication by Sberro‐Soussan et al on page 681.